1 Followers
26 Following
satish

satish

Ophthalmic Lasers Market - Real Time Analysis & Forecast 2018 – 2026

Ophthalmic lasers are used for treatment of wide range of eye problems. Significant accuracy, low-cost, safe procedure, and convenient ophthalmic tools has increased the demand for ophthalmic lasers. Patients prefer ophthalmic lasers treatment due to pain free procedures and easy availability on an outpatient basis.

The main constituents of an ophthalmic laser system include foot pedal, laser console, and laser delivery system. The laser energy is transmitted to the patient’s eye by varied delivery systems, which are connected to the console by a fiber optic cable, an operating microscope, a slit lamp or an indirect ophthalmoscope. Ophthalmologists and eye surgery devices manufacturers are studying on medical uses of lasers, from cataract surgery to diagnostic retinal imaging. For instance, Sight Sciences, Inc., has its SLT laser device in clinical trials for study in patients with open angle glaucoma.

 

According to World Health Organization (WHO), in 2010, around 39 million people were blind among 285 million visually impaired people. The World Health Assembly has approved Action Plan 2014–2019 for the universal access to eye health, a pathway for Member States, WHO Secretariat, and International Partners, with the aim of achieving a reduction of around 25% of visual impairments by 2019.

 

Request For Sample Copy Of This Research Report: https://www.coherentmarketinsights.com/insight/request-sample/1071

 

Increasing population suffering from age related macular degeneration are expected to fuel growth of the ophthalmic lasers market

According to World Health Organization (WHO), in 2014, the uncorrected refractive errors was the prominent reason for moderate and severe visual impairment, globally. Cataracts is the main cause of blindness among people in underdeveloped countries and approximately 90% of visually impaired people live in emerging countries, indicating need of ophthalmic treatments. According to an estimation by CDC, the total number of cataract patients is expected to increase to 30.1 million by 2020.

 

According to Centers for Disease Control and Prevention (CDC), in 2015, around 11 million people in the U.S., aging 12 years and above, have vision impairment, which could be improved by correcting refractive errors. Moreover, around 3.3 million people in the U.S., aged 40 years and above were estimated as legally blind or with low eye functioning.

 
Diabetes is a major cause of retinopathy and rising awareness among the population towards solutions for visual impairment, easy procedure of the surgery, increasing government initiatives are some of the factors driving growth of the ophthalmic lasers market. According to World Health Organization (WHO), the number of people with diabetes was estimated to around 422 million in 2014 and is expected to increase in the near future.

 

Rapid advancement in technology is expected to drive growth of the ophthalmic lasers market

The global ophthalmic lasers market is segmented on the basis of laser type, applications, end user, and geography. New technologies like Lasik and Intra Lasik are expected to drive the growth of the market.

On the basis of laser type, the global ophthalmic lasers market is segmented into:

  • Nd: YAG Laser

  • Frequency Doubled Green Laser

  • SLT Laser

  • Excimer Laser

  • Femtosecond Laser

  • Cyclodiode Laser

 
Regional segmentation of the ophthalmic lasers market by Coherent Market Insights comprises, North America, Europe, Latin America, Asia Pacific, Middle East, and Africa. North America is expected to hold a dominant position in the global ophthalmic lasers market. This is mainly owing to presence of key players such as Abbott Medical Optics and Iridek Corporation, which are focusing on research and development and availability of adequate number of ophthalmologists.

 

Key players operating in the ophthalmic lasers market are IMRA America, Inc., Newport Corporation, Abbott Medical Optics, Alcon, Bausch & Lomb, Carl Zeiss Meditec, and Ziemer Ophthalmic Systems, Optotek, Nidek, Schwind, Lumenis.

 

Click to read more on Ophthalmic Lasers Market

 

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Single Cell Analysis Market Professional Survey Report Trends, Growth Rate, Segment And Forecasts To 2026

Single cell analysis is an emerging technology that helps sequence whole human genome at a single cell level. This particularly includes genomics, transcriptomics, proteomics, epigenomics, and metabolomics with its sensitivity improved to single cell level. In genomics, new generation methodologies such as next generation sequencing and third generation sequencing play crucial roles. The aim of single cell analysis is mainly to measure and analyze cellular heterogeneity. Single cell analysis interpret life at fundamental level and find immense applications in the field of medicine. Single cell analysis over conventional standard cell numbers sequencing method enable the discovery and investigation of unknown micro-organisms.

A study published in the Journal of Single Cell Analysis 2014, stated that a variety of technologies that are powerful and less expensive, such as Multiple Annealing And Looping-Based Amplification Cycle (MALBAC) and Multiple Displacement Amplification (MDA), find great progress in uncovering somatic mutations in human genome and detection of copy number variation. But in human single-cell genomics, Whole Genome Sequencing or Whole Exome-Sequencing (WGS or WESseq) finds great potential in clinical applications, especially in screening, diagnosis, and monitoring. It is popular in academic research because mRNA helps bridge genome structure and epigenomics modification with phenotype, reveals gene functions and regulatory network, and most importantly it is easier to perform than proteomics.

 

Request For Sample Copy of This Research Report: https://www.coherentmarketinsights.com/insight/request-sample/1078

 

Inclination toward single-cell technology by biologists is mainly because many samples including stem cells, immune cells, neurons, cancers, and other tissues exhibit a stochastic nature with heterogeneity factor. Conventional methods cannot provide transcriptomic profile in highly heterogeneous cell population. Even if cell population is less, single cell analysis can enable the identification of biomarkers of delicate phenotypes or disorders (e.g. cancer stem cells). In addition, this analytical technique also helps classify different cell types in different physiological and pathological conditions, in very rare events of any somatic mutation, epigenetic modification of regulatory gene expression, and its function.

 

Global Single Cell Analysis Market Taxonomy

The global single cell analysis market is segmented on the basis of product, types of cells, type of technique, application, and end user.

By product:Consumables (beads, microplate, reagents, assay kits, etc.), Instruments (PCR, NGS system, spectrophotometers, etc.), Automated, Manual

10x Genomics, in 2017, launched the chromium single cell V(D)J solution for profiling full length paired V(D)J transcripts from hundreds to millions of lymphocyte. It is a reagent system, which has the ability to completely identify and characterize T and B cells by single cell sequencing. This will reveal true clonality and diversity in adaptive immune system. This product will have an impact on research based single cell analysis market.

By Types of cells: Human, Animal, Microbial

By Type of technique: Mass Spectroscopy (MS), Polymerase Chain Reaction (PCR), Next-Generation Sequencing, Flow Cytometry, Microscopy,

 

Adoption rate of treatment options, for instance, stem cell therapy and in-vitro fertilization (IVF) is increasing significantly.

Long shelf life of single cell analysis products and consumable products is another driver for the growth of single cell analysis market.

However, high cost of instruments may have a negative impact on market growth in future.

 

Global Single Cell Analysis Market – Trends and Opportunity

A study by the Journal of Analytical and Bioanalytical Chemistry in 2014, stated that Inductively Coupled Plasma Mass Spectroscopy (ICP-MS) and ICP Optical Emission Spectrometry (ICP-OES) are applied using metal atoms such as nanoparticle for investigation of cell-to-cell variance or cellular uptake of drugs and other elements. Single-cell genomics find many clinical applications such as genetic diagnosis of embryo-related diseases and to study blood-borne Circulating Tumor Cells (CTCs). These applications may be further employed for diagnosis, prognosis, and treatment of cancer.

Major key players in the global single cell analysis market include 10X Genomics, Abcam Plc., Agilent Technologies, Fluxion Biosciences, Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., Bio-Techne Corporation, Bruker, Danaher Corporation, Fluidigm Corporation, GE Healthcare, and Illumina, among others.

Click to read more on Single Cell Analysis Market

 
About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Weight Management Market - Dynamic Business Environment during 2018 – 2026

Weight management is an approach to a attaining and maintaining a healthy lifestyle. Weight management includes a healthy balanced diet and physical exercise, to maintain energy intake and energy expenditure. An individual with healthy eating habits can control under-consumption and over-consumption of food. Fad diets that promote fast and temporary weight loss are not included in weight management, rather such management programs focuses on slow weight loss to attain ideal body weight.

Globally, the obese population is increasing, in turn, increasing the incidence of chronic diseases such as musculoskeletal disorders, cardiovascular diseases, hypertension, and diabetes. Treatment of such diseases is highly expensive thus, increasing the demand for weight management programs. According to World Health Organization (WHO) estimation, in 2016, 13% of the world’s adult population was obese, particularly 15% of women and 11% of men population globally. From 1975 to 2016, the prevalence rate of obesity almost tripled. This in turn, is expected to create immense potential for growth of the weight management market.

 

Request for Sample Copy of This Research Report: https://www.coherentmarketinsights.com/insight/request-sample/1057

 

Global Weight Management Market Taxonomy

On the basis of product type, the global weight management market is segmented into:

  • Equipment

    • Fitness Equipment

      • Cardiovascular Training Equipment

      • Strength Training Equipment

      • Body Composition Analyzers

      • Fitness Monitoring Equipment

    • Surgical Equipment

      • Minimally Invasive

      • Non-invasive

North America held a dominant position in the global weight management market

Geographically, North America is expected to hold a dominant position in the market, owing to increasing intake of junk food and improper lifestyle among the populace in the region. Asia Pacific is projected to register highest growth during the forecast period. This growth is primarily attributed to growing awareness of management of body weight to avoid adverse health effects among the populace coupled with emerging medical tourism and healthcare infrastructure in the region.

The weight management market is expected to evolve with the development of novel technologies. For instance, in 2017, Neurovalens raised around US$ 1.6 million in crowdfunding. For the development of Modius, a headband that stimulates the brain to control metabolism and fat storage, boosting the former, while decreasing the individual’s appetite. Furthermore, StayWell acquired MedHelp’s health engagement platform. The acquisition helped the company reach 3 million users of the MedHelp Company and incorporate MedHelp’s Sugar Sense and My Diet Diary apps to its existing diabetes management and weight loss solutions portfolios.

The global weight management market is highly fragmented with several companies operating locally. To increase their footprint in the market, major players are adopting strategies such as new product launches, partnerships, acquisitions, and agreements. In October, 2017, EnteroMedics Inc. acquired ReShape Medical Inc. The acquisition added ReShape Medical’s FDA-approved ReShape Dual Weight Loss Balloon, a minimally invasive intragastric balloon to treat obese people. This product will complement EnteroMedical’s weight loss solutions portfolio.

 

Some of the key players operating in the global weight management market include Herbalife International Inc., NutriSystem Inc., EnteroMedical Inc., StayWell Inc., Weight Watchers International Inc., Brunswick Corporation, Ethicon US LLC, Ajinomoto Co. Inc., Abbott Nutrition, eDiets.com, Atkins Nutritionals, McNeil Nutritionals, Duke Diet and Fitness Center, Life Time Fitness Inc., Precor Inc., Fitness First Group, and 24 Hours Fitness.

Click to read more on Weight Management Market

 

About Coherent Market Insights:
Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Single Cell Analysis Market – Robust pace of Industry during 2018-2026

Weight Management Market, report categorizes the report by Product Type, Surgical Equipment, Supplements, End User and geography. It provides information about - Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2018–2026

U.S. Opioids Market Key players, competitors, regional outlook forecast 2018-2026

Opioids can be defined as a class of drugs, which include the drug heroin, synthetic opioids such as fentanyl, and various pain relievers prescribed legally, such as oxycodone, hydrocodone, and others. This class of drug is primarily taken for pain relief. It has been used for other medical purposes including cough and diarrhea treatment. They bind to opioids receptor and produce a desirable result. Opioids are generally safe when taken for a short time, regular use of the drug can lead to dependence and in extreme cases may even result in death.

 

Market Dynamics

According to the National Institutes of Health (NIH) estimates, in 2015 by the American Pain Society, nearly 50 million people in the U.S. suffered from chronic pain. Use of opioids in cancer, orthopedic, neuropathic, post-operative pain, and lower back pain is very effective. With growing incidence of chronic pain demand for opioids is also expected to increase consequently. Moreover, opioid overdose or abuse has fueled the growth of the U.S. opioids market. CVS Health’s, leading pharmacy chain, reports that company had been often asked to fill the prescription of 30 to 60 of the powerful pills at a time for conditions that required a much more limited amount.

 

Request for Sample Copy of This Research Report: https://www.coherentmarketinsights.com/insight/request-sample/1048

 

Key features of the study:

  • This report provides in-depth analysis of the U.S. opioids market size (US$ Million) and Cumulative Annual Growth Rate (CAGR (%)) for the forecast period: 2016 – 2024, considering 2015 as the base year

  • It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market

  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by the leading players

Detailed Segmentation:

  • U.S. Opioids Market, By Drugs

    • Codeine

    • Fentanyl

    • Meperidine

    • Methadone

    • Morphine

    • Hydrocodone

 

Crisis in the U.S. Opioids Market

According to the New York Times analysis of state data, in 2016, drug overuse led to death of 59,000 to 65,000 people in the U.S. Around two-third of these deaths were due to opioids overuse and the number is expected to increase. According to a survey of National Institute of Drug Abuse (NIDA), deaths due to the overdose prescription of opioid pain relievers have more than tripled in the past 20 years, escalating to 16,651 deaths in the U.S. in 2010. It can be concluded from the analysis of the data (data from the survey and New York Times data), that death due to opioids have more than doubled in the past six years.

 
Increasing incidences of chronic pain is expected to drive growth of the U.S. opioids market

According to the American Academy of Pain Medicine (AAPM), 2011, around 1.8 billion people suffered from chronic pain. Moreover, according to the National Institute of Health (NIH) estimates in 2015, one in 10 people in the U.S. suffered from chronic pain. Increasing prevalence of chronic pain is expected to result in high prescription of opioids pain relievers, which in turn is expected to fuel the market growth. Easy availability and favorable insurance policy are other major drivers for growth of the U.S. opioids market.

 

Cannabis as potential alternative for pain relief can be a threat to the U.S. opioids market

Cannabis could be the alternative therapy for opioids. Currently, medical marijuana is legal in 28 states and the District of Columbia even though it is illegal under federal law. According to a research published in Annals of Internal Medicine, in majority of cases, between 45% and 85%, medical marijuana is used for pain management. However, there is some ambiguity about medical marijuana effectiveness in pain management. Cannabis could be used as effective therapy after establishment of clinical trials.

Some major players operating in the U.S. opioids market include Purdue Pharma L.P., Titan Pharmaceuticals, Inc., Boehringer Ingelheim GmbH, Janssen Pharmaceuticals, Inc., Sanofi S.A., Sun Pharmaceuticals Industries Limited, Mallinckrodt Pharmaceuticals, Egalet Corporation, Endo Pharmaceuticals plc, Allergan, plc, and Pfizer Inc.

Click to read more on U.S. Opioids Market

 

About Coherent Market Insights:
Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Global Medical Animation Market Predicted to Accelerate the Growth by 2018-2026

Medical animation is an integral part of any medical technology, as it can deliver a clear details about medical technology. The development in computer software and hardware with the efforts by various universities have developed a link between science and art, which led to a formation of new generation of information, technology, and designers in the medical field for both scientific and medical illustration purposes. The combination of scientific analysis with high end computer graphics and animation capabilities is expected to take the medical sector to the next level of advancement. Rising prevalence of cancer followed by rising R&D activities using 3D animation technology for visualization during new drug development will create the demand for animated studies to explain the drug mechanisms expected propel the industry growth over the forecast period. As, 3D animation is one of the adopted medical animation type by companies that enable better sense and depth of procedure or a particular product which helps to capture the interest and leave a positive impression or motivate people to make a purchase.

The global medical animation market is valued at US$ 176.60 million in 2017 and is expected to witness a CAGR of 19.3% over the forecast period (2017 – 2025).

 

Request For Sample Copy of This Research Report: https://www.coherentmarketinsights.com/insight/request-sample/1031

 

Market Dynamics

The companies are adopting competitive strategies such as new product development, merger & acquisitions and technology upgradation to sustain in the medical animation competitive market. For instance, In July 2017, Random42 was acquired by Graphite Capital, a mid-market private equity firm. Random42, which provides high-quality medical animation and digital media services to the healthcare and pharmaceutical industry was planning to expand geographically in Europe while continuing to grow its North American sales. Investment from graphite capital could help it to meet its objective. By the use of computer technology, the medical animators can create short movies, which could be used in various applications such as, patient education, emergency care education, drug formula simulation and various other purposes. This in turn expected to create lucrative opportunities for the medical animation market. On the flip side, time constraint is a major factor that may hamper the growth of medical animation market as there are several feedback rounds, and at two points the client’s legal, regulatory and medical approval is needed for the production.

 

Key features of the study:

  • This report provides in-depth analysis of medical animation market and provides market size (US$ Million) and Cumulative Annual Growth Rate (CAGR %) for the forecast period (2017–2025), considering 2016 as the base year

  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrix for this market

  • This study also provides key insights about market drivers, restraints, opportunities, regulatory scenario, regional outlook, and competitive strategy adopted by the leading players

 

Detailed Segmentation:

  • Global Medical Animation Market, By Type:

    • 2D, 3D, 4D, Flash Animation

 

Promotion of the new product launches by manufacturers with the help of animated companies is a prominent factor fueling market growth

Increasing adoption of medical animation techniques by healthcare professionals for demonstrating medical procedures or other scientific purposes with a significantly higher comprehension is expected to propel growth of the medical animation market. Since this technology aids in educating patients, an increasing patient enrolment in disease management or wellness programs is witnessed. This showcases the potential for this technology in near future. Fusion of this medical animation into the mobile apps by combining real time media rich content with measurable data and configurable tools for various medical device and pharmaceutical company sales is also expected to create a lucrative opportunities for the growth of the medical animation market.

On the basis of regional segmentation, the global medical animation market can be segmented into North America, Europe, Asia Pacific, Latin America, Middle East, and Africa. North America is expected to account for the largest share followed by Europe and Asia Pacific. Medical animation market in North America is driven by factors, such as increasing number of pharmaceutical companies using animation for product promotion and medical education, and rising penetration of electronic devices such as smartphones. Therefore, the companies are adopting competitive strategies such as new product development, merger & acquisitions and upgrading technology to sustain in the medical animation competitive market.

 

The key players operating in the global market of medical animation include Infuse Medical, Hybrid Medical Animation, Inc., Ghost Productions, Inc., Scientific Animations, Inc., INVIVO Communications, Inc., Random42 Scientific Communication, Radius Digital Science, Nucleus Medical Media, Inc., AXS Studio, Inc., Trinsic Animation, and Medmovie Inc.

 

Click to read more on Global Medical Animation Market

 

About Coherent Market Insights:
Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

ADME Toxicology Testing Market Product Type, Segment by Regions and Scope Till 2026

ADME is an abbreviation in pharmacokinetics and pharmacology, stands for absorption, distribution, metabolism and elimination of chemicals and drugs to define the impact in a human body. Toxicology testing is a significant event before an introduction of new drugs into the market. However, drug development is very crucial stage of the pharmaceutical and biotechnology manufacturer as it is attributed to high costs at the various stages of drug development. Thus, one of the key factors linked to the last stage drug failure is due to inability of new drug candidates to meet human and animal safety profile. To overcome this barrier of drug failure, ADME toxicology testing has a major advantage to enter in early drug development phase of pre-clinical trials.

 

ADME toxicology testing influence the drug levels and kinetics of drug exposure to the body tissue and hence facilitated the performance in pharmaceutical manufacturing by minimizing drug discovery time, complications in testing and reduction in overall cost in drug development. Thereby, pre-clinical ADME toxicology testing is a substantial application in drug discovery venture capital (VC) industries to make financial decisions in corresponds to significance and scope in the drug discovery firms. Which is expected to gain more traction of the ADME (absorption, distribution, metabolism and elimination) toxicology testing market over the forecast period.

 

Request For Sample Copy of This Research Report: https://www.coherentmarketinsights.com/insight/request-sample/1013

 

Global ADME (Absorption, Distribution, Metabolism and Elimination) Toxicology Testing Market Taxonomy:

On the basis on type of product and technology, global ADME (absorption, distribution, metabolism and elimination) toxicology testing market segmented into:

By product:

  • Instruments, Assay Systems, Software Solutions, Reagents, Others

By Technology:

  • In-silico Testing, In-vitro Testing, In-vivo Testing

 

An effort for early stage drug development by biopharmaceuticals and growing demand for CRO’s advanced ADME toxicology testing is expected to propel the ADME (absorption, distribution, metabolism and elimination) toxicology testing market

In October, 2014, Wuxi Pharma Tech announced that it has acquired Xenobiotic Laboratories, Inc. (XBL) to aid its bioanalytical, drug metabolism and pharmacokinetic (DMPK) and ADME (absorption, distribution, metabolism and elimination) services for radio-labeled compounds. Wuxi Pharma Tech’s intends in integrated service portfolio to expand laboratory testing division in North America.

Furthermore, in January, 2014, a specialist ADME-Tox Contract Research Organization (CRO) - Cyprotex PLC entered into an acquisition agreement with an initial financial value of US$ 0.73 million for the business and assets of CeeTox, Inc. The Cyprotex intends to expand the portfolio in in-vitro toxicity assays and screening services to the Cosmetics and Personal Care Industry.

 

Evotec AG, who offers drug research, development, and its manufacturing services to pharmaceutical company, announced the completion of acquisition with Cyprotex PLC in December, 2016. The deal was designed to enhance Evotec’s ADME-Tox platform, in vitro ADME screening, high-content toxicology screening and mechanistic and, predictive modeling to strengthen its buyer’s drug discovery efforts for an early stage drug development and this deal was closed in US$ 67.6 million. Thereby, is expected to stimulate the ADME (absorption, distribution, metabolism and elimination) toxicology testing market growth over the forecast period.

However, lack of in-vitro models to detect autoimmunity and immune-stimulation may hamper the market growth to some extent.

 

Increasing demand for cell-based assay by bio-pharmaceutical company is expected to boost the ADME (absorption, distribution, metabolism and elimination) toxicology testing market

Growing adoption of ADME toxicology testing by biotechnology and pharmaceuticals and increasing demand for cell-based assays in drug discovery is major driving factor fueling the ADME (absorption, distribution, metabolism and elimination) toxicology testing market growth. For instance, in September, 2017, a leading provider of bio specimens and its related services, BioIVT has announced an acquisition agreement with Qualyst Transporter Solutions, LLC. Qualyst’s cell-based testing approach provides in vitro hepatic models and services which helps in the prediction of the effect of drugs and other compounds in the human liver. Thus, BioIVT enables to predict its new drug impact on the liver. As ADME testing has proven to be an efficient time and cost testing procedures.

Key player in ADME (absorption, distribution, metabolism and elimination) toxicology testing market include, Agilent Technologies, Inc., Cellartis AB, Bio-Rad Laboratories, Inc., Thermo Fisher Scientific, Inc., Molecular Discovery Ltd, Caliper Life Sciences, Inc., Cyprotex PLC, Optivia Biotechnology, Inc., Promega Corporation and Beckman Coulter, Inc.

Click to read more on ADME Toxicology Testing Market

 

About Coherent Market Insights:
Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

U.S. Opioids Market Key players, competitors, regional outlook forecast 2018-2026

Opioids can be defined as a class of drugs, which include the drug heroin, synthetic opioids such as fentanyl, and various pain relievers prescribed legally, such as oxycodone, hydrocodone, and others. This class of drug is primarily taken for pain relief. It has been used for other medical purposes including cough and diarrhea treatment.

Medical Animation Market - Industry outlook and data collected 2018-2026

Medical animation is an integral part of any medical technology, as it can deliver a clear details about medical technology. The development in computer software and hardware with the efforts by various universities have developed a link between science and art, which led to a formation of new generation of information, technology, and designers in the medical field for both scientific and medical illustration purposes.

ADME Toxicology Testing Market Upcoming Trend And Value Chain To 2026

U.S. Hospital Beds Market – Industry outlook and data collected 2018-2026

Hospital beds are serving the purpose of patient care in various medical institution and residences. Hospital beds are versatile and robust, in terms of ease to clean, maintenance as compared to household bed for a longer period of time. Hospital beds can be set to any inclination as per the patient’s comfort with the help of levers fixed to the beds. Moreover, most of the modern hospitals provide electric and semi-electric beds, which cut down the need of medical assistance for patient monitoring as well as movement. Hospital beds are conventionally used in various patient care settings, such as intensive care unit beds, psychiatry beds, ambulatory, pediatric beds, terminal patient beds, outpatient beds, bariatric beds, and maternity beds.

 

Request For Sample Copy of This Business Report: https://www.coherentmarketinsights.com/insight/request-sample/996

 

Market Dynamics

The U.S. hospital bed market is gaining significant traction due to rising geriatric population associated diseases. For instance, according to Population Reference Bureau (PRB), in 2016, around 46 million people were aged 65 years and older in the U.S. and by 2060 population is predicted to be 98 million. Geriatric population is more susceptible to infections, which raises the demand for public health system to increase the number of beds in the hospitals. This is expected to boost the growth of the U.S. hospital bed market over the forecast period. Furthermore, in October 2017, Highmark Health announced to build a new 160-bed hospital in Pine Township (U.S.). Highmark aims to make healthcare more affordable. This new hospital is expected to get regulatory approval in mid-2018 and complete by 2021.

 

Detailed Segmentation:

  • U.S. Hospital Beds Market, By Type:

    • Electric Beds

    • Semi-electric Beds

    • Manual Beds

Key features of the study:

  • This report provides in-depth analysis of the S. Hospital Beds Market and its device type, market size (US$ Million), and Cumulative Annual Growth Rate (CAGR %) for the forecast period: 2017 – 2025, considering 2017 as the base year.

  • It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market.

  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by the leading players.

 

Factors such as rising number of road accidents, sports injuries, and associated chronic infections mainly needs a surgery, which will drive growth in the hospital beds market in the U.S. For instance, according to World Health Organization (WHO), 2017, road traffic injuries are the leading cause of death among people aged between 15 and 29 years. High cases of bed-ridden and traumatic brain injury-related emergency patients demands longer hospital stays, in turn raising the demand for the hospitals beds, which is expected to propel the immense growth of the U.S. hospital beds market over the forecast period.

For instance, according to the Centers for Disease Control and Prevention (CDC), in 2013, around 2.8 million traumatic brain injury-related emergency department (ED) hospitalizations, visits, and deaths were estimated in the U.S. Traumatic brain injury estimated around 282,000 hospitalizations and around 2.5 million reported emergency department visits in the U.S. According to the data of CDC, it represents high prevalence of traumatic brain disorders, which requires constant care and longer hospital stays which in turn increase demand for hospital beds. This will fuel the growth of the U.S. hospital beds market over the forecast period.

 

Initiatives taken by the U.S government and healthcare organizations for proper disease management requiring long stay in hospital is expected to witness the growth of the U.S hospital beds market

In October 2017, U.S. navy’s hospital ship named USNS Comfort, designed a bed to treat people in disaster strike. The USNS comfort ship has 1,000 patient beds, which includes 80 intensive care bed and 12 operating rooms for both civilian and military. Furthermore, to improve healthcare facilities for the maximum patient outcome, Highmark has announced to build 160-bed hospital in Pine Township. Highmark is intended to provide affordable healthcare service in the U.S. Highmark is expected to get regulatory approval in mid-2018 and project completion in 2021. Thus, this portfolio aims to improve healthcare service for better treatment management, which is expected to boost the growth of U.S. hospital beds market growth over the forecast period.

Click to read more on U.S. Hospital Beds Market

 

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Medical Waste Management Market 2018 Global Industry – Key Players, Size, Trends,

Medical Waste Management Market Opportunities, Growth Analysis and Forecast to 2026

Healthcare activities generates a lot of waste, especially from the frequently used consumables, which are harmful for in-patients and healthy population. Medical waste includes waste generated within research centers and health-care facilities for example, sharps waste, infectious waste, pathological waste, pharmaceutical waste, chemical waste, and radioactive waste. The waste product that are generated by the healthcare activities have higher potential to spread infection and injuries. Inadequate or incorrect handling of medical waste may cause serious public health issues such as HIV, tuberculosis, hepatitis, and other bacterial diseases and also have irreversible impact on the environment.

According to Journal of Hospital Infection, in 2013, around 20% of medical waste cause risks of trauma, infection, chemicals or radiation exposure. Effective medical waste management is crucial for environment and health protection. According to World Health Organization (WHO), in 2015, around 16 million syringes are administrated every year, among which only few are disposed properly, in turn creating risk of injuries and infection. Moreover, UNICEF and WHO collaborated in 2015, launched a global initiative to ensure that all healthcare facilities have proper and adequate water, hygiene, and sanitation services, which also include healthcare waste disposal management. Various strategies are adopted by national and international bodies on the development and implementation on education and training programs for medical staff and patients, emphasizing on proper medical waste management.

 

Request For Sample Copy of This Research Report: https://www.coherentmarketinsights.com/insight/request-sample/987

 

Medical Waste Management Market Taxonomy

By Technique:

  • Incineration

  • Autoclaving

  • Chemical treatment

  • Others

 

Proper medical waste management in developed and emerging economies is expected to fuel growth of the medical waste management market

Government initiatives to support medical waste management is encouraging effective medical waste management. For instance, the Union Ministry of Environment, in 2017, issued a guideline for developing bar codes in the hospitals and clinics in compliance with Bio-medical Waste Managements, rule 2016. This aims to monitor the source of generation of medical waste and its proper disposal, which in turn is expected to control the hazardous effects caused by medical waste. This initiative by the government is expected to propel growth of the medical waste management market in the near future. Training given to the hospital staff to separate and dispose waste properly is critical for the success of such programs or initiatives. Developed regions such as North America and Europe are adopting proper medical waste management. For instance, many hospitals in U.S. have started recycling the single-use products, which are sold back to the hospitals at fraction of the original cost.

 

Strict rules imposed by government for proper disposal of medical waste is expected to augment medical waste management market growth in the near future

Incineration is the most commonly used method for disposing medical waste, however, it is not a safe procedure as it emits lots of gases, which are responsible for global warming. Environment Protection Agency (EPA) have imposed strict rules regarding incineration due to increasing global warming. Strict rules imposed by government bodies for proper medical waste disposal such as recycling and emission, is increasing the demand for medical waste management. Various non-incineration techniques are used such as autoclave treatment, non-ionization treatment, and some chemical treatment. Government and non-government bodies are working by spreading awareness among masses for proper technique of disposing medical waste in non-hazardous state. The key market players operating in the global medical waste management market include Stericycle, Sharps Compliance, Inc., Veolia Environment, Daniels Sharpsmart, Clean Harbors, Inc., MedWaste Management, Republic Services, and Waste Management.

 

Click to read more on Medical Waste Management Market

 

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Wearable Injector Market with High CAGR in Coming Years 2026 with Focusing Key Players

Wearable Injector Market report categorizes the report by Product type, Usage, Technology, Application, end-User and geography. It provides information about - Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2018–2026

Wearable Injector Market Sustains Competitiveness by Adoption of Technological Innovations 2026

Drugs are mostly viscous and has various formulations (intravenous, intramuscular, and subcutaneous) that needs to be absorbed into digestive tract, which raise multiple drug delivery issue with traditional drug delivery system. Moreover, such issues not only raise costs but also decrease satisfaction and compliance of patients. Wearable injectors or bolus injectors are the new class for drug delivery device designed for subcutaneous delivery. It has capacity to hold the drug volume of up to 2.5 ml. Wearable injectors are easy to handle, low cost, disposable, and allow self-administration. Advancement in injector technology over traditional drug delivery system include single button to release the drug and after completion of drug in body, the needle is retracted and gets locked automatically. Thus, it’s safe and convenient disposable system benefits people who has needle phobia. Furthermore, it allows audible and visual signals, which is expected to fuel the growth of wearable injector market during forecast period.

 

Request Sample Copy of This Research Report: https://www.coherentmarketinsights.com/insight/request-sample/970

 

Strategies to improve drug delivery system through the introduction of new wearable injectors is expected to propel the growth of wearable injector market

In 2015, Unilife Corporation introduced Imperium, which is an instant patch pump used for insulin. Imperium is a subcutaneous insulin infusion, disposable, prefilled, and multi-day wearable insulin pump. It has various features that include data connectivity for app to constantly remind and update wireless connectivity such as Bluetooth LE. It also provide real-time access to healthcare provider to track the insulin therapy of each patient.

In 2014, Enable Injections LLC has signed an agreement with CSL Behring to develop novel drug delivery devices. Enable Injectors intent to improve comfort, convenience, and compliance administrative device for the patients with rare diseases.

Enable Injection LLC and Flex entered in agreement to develop and manufacture wearable medical device in 2016. Enable and Flex aims to develop subcutaneous pain-free injection technology with features such as Bluetooth connectivity, monitoring system with smartphone app, mix automation, and passive warming system.

 

Wearable Injector Market Taxonomy:

By Product type

  • On-body (Adhesive patch)

  • Off-body (Belt clip)

  • Hand-Held

 

Increasing prevalence of chronic diseases and high demand for advanced drug delivery device for frequent administration of drug is expected to augment the market growth

According to the World Health Organization (WHO), around 1.6 million deaths caused by diabetes in 2015 and is expected to increase by more than 50% before the age of 70 years by 2030. Moreover, According to National Institute of Health (NIH), in 2017, around 23.5 million people are suffering from autoimmune diseases in U.S.

According to World Health Organization (WHO), in 2017, nearly 1 in every 6 death occurs due to cancer globally and approximately 70% of deaths from cancer occur in low and middle-income countries. Increasing prevalence of chronic disease and high demand for advanced drug delivery devices for frequent administration of drugs is expected to fuel the growth of wearable injector market during the forecast period.

Some of the key players operating in the global wearable injector market include Medtronic Plc, West Pharmaceutical Services, Inc., Enable Injections, F. Hoffmann-La Roche Ltd, scPharmaceuticals, Inc, Johnson & Johnson, Insulet Corporation, Sensile Medical Ag, Becton, and Dickinson And Company.

 

Click to read more on Wearable Injector Market

 

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

HbA1c Testing Devices Market Global Analysis, Share, Trends, And Forecast 2018– 2026